Additionally, other members of the NGF pathway showed an ability to differentiate DSAD from asymptomatic DS at levels similar to, or exceeding that of core AD biomarkers (tTau, pTau, ab40/42 ratio) [106]. Here, NGF is linked to Alzheimer disease.